有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | 2-[(4-Ethyl-5-propyl-1,2,4-triazol-3-yl)sulfanylmethyl]-5-propyl-1,3,4-oxadiazole | —— | C13H21N5OS |
|
—— | Methyl 2-[(5-ethyl-1,3,4-oxadiazol-2-yl)sulfanyl]acetate | —— | C7H10N2O3S |
|
—— | Ethyl 2-[(5-ethyl-1,3,4-oxadiazol-2-yl)sulfanyl]acetate | —— | C8H12N2O3S |
|
—— | 2-[(5-ethyl-1H-1,2,4-triazol-3-yl)sulfanylmethyl]-5-propyl-1,3,4-oxadiazole | —— | C10H15N5OS |
|
—— | 2-[(4-Ethyl-5-propyl-1,2,4-triazol-3-yl)sulfanylmethyl]-5-phenyl-1,3,4-oxadiazole | —— | C16H19N5OS |
|
—— | 2-[(5-benzyl-1H-1,2,4-triazol-3-yl)sulfanylmethyl]-5-propyl-1,3,4-oxadiazole | —— | C15H17N5OS |
|
—— | 2-Methyl-5-[(5-propyl-1,3,4-oxadiazol-2-yl)methylsulfanyl]-1,3,4-oxadiazole | —— | C9H12N4O2S |
|
—— | 6-Amino-5-[2-(4-bromophenyl)sulfanylacetyl]-3-methyl-1-propylpyrimidine-2,4-dione | —— | C16H18BrN3O3S |
|
—— | (2S)-2-(4-bromophenyl)sulfanyl-N-(1-cyanocyclohexyl)propanamide | —— | C16H19BrN2OS |
|
—— | (Z)-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]-3-[(4S)-3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-yl]prop-2-enoate | —— | C16H13N4O4S- |
|
—— | (2R)-2-(4-bromophenyl)sulfanyl-N-(1-cyanocyclohexyl)propanamide | —— | C16H19BrN2OS |
|
—— | methyl 3-[2,5-dimethyl-3-[2-(1H-1,2,4-triazol-5-ylsulfanyl)acetyl]pyrrol-1-yl]propanoate | —— | C14H18N4O3S |
|
—— | N-[(2S)-4-phenylbutan-2-yl]-2-(1H-1,2,4-triazol-5-ylsulfanyl)acetamide | —— | C14H18N4OS |
|
—— | (E)-3-[5-(azepan-1-yl)furan-2-yl]-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]prop-2-enoic acid | —— | C16H19N3O4S |
|
—— | 1-[(3S)-3-(furan-2-yl)-5-(4-methylphenyl)-3,4-dihydropyrazol-2-yl]-2-(1H-1,2,4-triazol-5-ylsulfanyl)ethanone | —— | C18H17N5O2S |
|
—— | 2-thiophen-2-yl-4-(1H-1,2,4-triazol-5-ylsulfanylmethyl)-1,3-oxazole | —— | C10H8N4OS2 |
|
—— | (Z)-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]-3-(1,2,5-trimethylpyrrol-3-yl)prop-2-enoate | —— | C13H14N3O3S- |
|
—— | (Z)-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]-3-[(4S)-3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-yl]prop-2-enoic acid | —— | C16H14N4O4S |
|
—— | 1-[1-[(4-fluorophenyl)methyl]-2,5-dimethylpyrrol-3-yl]-2-(1H-1,2,4-triazol-5-ylsulfanyl)ethanone | —— | C17H17FN4OS |
|
—— | (Z)-3-(5-bromothiophen-2-yl)-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]prop-2-enoic acid | —— | C10H7BrN2O3S2 |
|
—— | methyl 2,4-dimethyl-5-[(2S)-2-(1H-1,2,4-triazol-5-ylsulfanyl)propanoyl]-1H-pyrrole-3-carboxylate | —— | C13H16N4O3S |
|
—— | 2-(1H-1,2,4-triazol-5-ylsulfanyl)-N-(2,2,2-trifluoroethyl)acetamide | —— | C6H7F3N4OS |
|
—— | N-[(3S)-1,1-dioxothiolan-3-yl]-N-(2-methylpropyl)-2-(1H-1,2,4-triazol-5-ylsulfanyl)acetamide | —— | C12H20N4O3S2 |
|
—— | (Z)-2-[[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-3-(5-methylfuran-2-yl)prop-2-enoic acid | —— | C16H11ClN2O4S |
|
—— | N-(1-adamantyl)-N-[(4-chlorophenyl)methyl]-2-(1H-1,2,4-triazol-5-ylsulfanyl)acetamide | —— | C21H25ClN4OS |
|
—— | N-[(2S)-2-phenylpropyl]-2-(1H-1,2,4-triazol-5-ylsulfanyl)acetamide | —— | C13H16N4OS |
|
—— | (E)-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]-3-(5-piperidin-1-ylfuran-2-yl)prop-2-enoic acid | —— | C15H17N3O4S |
|
—— | N-[(3R)-1,1-dioxothiolan-3-yl]-N-(2-methylpropyl)-2-(1H-1,2,4-triazol-5-ylsulfanyl)acetamide | —— | C12H20N4O3S2 |
|
—— | (Z)-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]-3-(5-phenylsulfanylfuran-2-yl)prop-2-enoic acid | —— | C16H12N2O4S2 |
|
—— | N-(1-adamantyl)-N-(furan-2-ylmethyl)-2-(1H-1,2,4-triazol-5-ylsulfanyl)acetamide | —— | C19H24N4O2S |
|
—— | (E)-3-(5-bromofuran-2-yl)-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]prop-2-enoic acid | —— | C10H7BrN2O4S |
|
—— | N-[(2S)-2-cyano-3-methylbutan-2-yl]-2-(1H-1,2,4-triazol-5-ylsulfanyl)acetamide | —— | C10H15N5OS |
|
—— | [5-(Furan-2-yl)-1,3,4-oxadiazol-2-yl]methyl 2-(4-bromo-2-methylphenyl)sulfanylacetate | —— | C16H13BrN2O4S |
|
—— | [2-[[(2R)-2-cyano-3-methylbutan-2-yl]amino]-2-oxoethyl] 2-(4-bromo-2-methylphenyl)sulfanylacetate | —— | C17H21BrN2O3S |
|
—— | (E)-2-(1,3-benzoxazol-2-ylsulfanyl)-3-(5-phenylsulfanylfuran-2-yl)prop-2-enoate | —— | C20H12NO4S2- |
|
—— | (Z)-2-[[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-3-(1,2,5-trimethylpyrrol-3-yl)prop-2-enoate | —— | C18H15ClN3O3S- |
|
—— | (E)-3-[5-(5-chloro-2-methylphenyl)furan-2-yl]-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]prop-2-enoic acid | —— | C17H13ClN2O4S |
|
—— | (Z)-2-[(5-ethyl-1,3,4-oxadiazol-2-yl)sulfanyl]-3-(3-methylthiophen-2-yl)prop-2-enoic acid | —— | C12H12N2O3S2 |
|
—— | (Z)-2-[(5-ethyl-1,3,4-oxadiazol-2-yl)sulfanyl]-3-[(4S)-3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-yl]prop-2-enoate | —— | C17H15N4O4S- |
|
—— | [2-(Methylamino)-2-oxoethyl] 2-(4-bromo-2-methylphenyl)sulfanylacetate | —— | C12H14BrNO3S |
|
—— | N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-(4-methylphenyl)sulfanylpyridine-3-carboxamide | —— | C21H18N2O3S |
|
—— | 2-[2-[(4-fluorophenyl)sulfanylmethyl]-5-methoxy-4-oxopyridin-1-yl]-N-(furan-2-ylmethyl)acetamide | —— | C20H19FN2O4S |
|
—— | Ethyl 2-[2-[(5-oxo-[1,3]thiazolo[3,2-a]pyrimidin-7-yl)methylsulfanyl]-1,3-thiazol-4-yl]acetate | —— | C14H13N3O3S3 |
|
—— | 1-(2,5-Dimethylphenyl)-3-[3-(4-fluorophenyl)sulfanylpropanoylamino]thiourea | —— | C18H20FN3OS2 |
|
—— | 1-[4-[(3S)-1,1-dioxothiolan-3-yl]piperazin-4-ium-1-yl]-2-(2,4,6-trimethylphenyl)sulfanylethanone | —— | C19H29N2O3S2+ |
|
—— | N-[(3S,4R)-4-chloro-1,1-dioxothiolan-3-yl]-2-(2,4,6-trimethylphenyl)sulfanylacetamide | —— | C15H20ClNO3S2 |
|
—— | 1-(2,5-Dimethylphenyl)-3-[[2-(4-methylphenyl)sulfanylacetyl]amino]thiourea | —— | C18H21N3OS2 |
|
—— | (2S)-N-benzyl-2-(2,4,6-trimethylphenyl)sulfanylpropanamide | —— | C19H23NOS |
|
—— | N-(furan-2-ylmethyl)-2-(2,4,6-trimethylphenyl)sulfanylacetamide | —— | C16H19NO2S |
|
—— | (2S)-N-cyclopentyl-2-(2,4,6-trimethylphenyl)sulfanylpropanamide | —— | C17H25NOS |
|